KFDA-certified stem cell facilities
Patented process meeting international standards
for stem cell isolation, culturing, and production
Cutting-edge platform applying advanced autologous stem cell therapy
Official Recognition
From the KFDA to the operating facilities, the entire system fully complies with the latest legal requirements, officially licensed to produce and supply stem cells to hospitals for clinical research.
Patent and Certification for autologous stem cell isolation, culturing, and production
AVANCED TECHNOLOGY
IMPLEMENTATION PROCESS
IMMUNE CELL TECHNOLOGY
CAR-T Cell Therapy For Cancer Treatment
VGCT is focusing on the development of immunotherapy and targeted treatments such as CAR-T therapy, a groundbreaking method that treats hematologic cancers by reprogramming a patient’s own T cells. The Group aims to establish a specialized CAR-T in vivo research laboratory, as well as build a stem cell bank for Vietnam and Southeast Asia, laying the foundation for precision biomedicine and enabling future cell storage and
distribution.
DECELLULARIZATION TECHNOLOGY
This advanced biotechnology enables the complete removal of cells from animal tissues while preserving the natural extracellular matrix (ECM)—such as collagen—providing a biological scaffold that reduces immune rejection and supports regeneration using human cells. VGCT’s strategic direction focuses on applying decellularization technology to regenerate tissues and “humanize” animal organs.
This approach opens new possibilities for replacing human organs with biocompatible biological materials, offering a sustainable solution to the global organ shortage and paving the way for the next generation of transplant medicine.
The biological ocular membrane product is expected to be used in corneal transplantation by early 2026, promising to bring significant advancements in ophthalmic treatment in Vietnam and the Southeast Asia region.
It meets international standards, including: GMP, ISO 13485, and ISO 10993.
APPLICATION OF GENE EDITING TECHNOLOGIES SUCH AS CRISPR/CAS9
In the face of growing climate change impacts on agricultural production, VGCT aims to apply advanced gene editing technologies such as CRISPR/Cas9 to develop climate-resilient crop varieties capable of withstanding extreme conditions such as drought, salinity, and pests. This initiative is part of VGCT’s vision
to build a smart bio-agriculture model, promoting digital transformation in farming, and contributing to the development of a sustainable, green, and technology-driven agricultural sector
